I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal ganglion cell | 4 studies | 65% ± 25% | |
| GABAergic neuron | 4 studies | 29% ± 10% | |
| glutamatergic neuron | 3 studies | 32% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal ganglion cell | 4 studies | 65% ± 25% | |
| GABAergic neuron | 4 studies | 29% ± 10% | |
| glutamatergic neuron | 3 studies | 32% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 4035.80 | 653 / 653 | 100% | 23.00 | 605 / 605 |
| brain | 99% | 4686.76 | 2612 / 2642 | 100% | 24.10 | 704 / 705 |
| prostate | 100% | 2965.77 | 245 / 245 | 96% | 6.19 | 484 / 502 |
| uterus | 100% | 3065.29 | 170 / 170 | 95% | 7.92 | 438 / 459 |
| esophagus | 98% | 2502.22 | 1416 / 1445 | 96% | 5.89 | 176 / 183 |
| lung | 99% | 1835.03 | 571 / 578 | 94% | 7.68 | 1089 / 1155 |
| intestine | 100% | 3440.24 | 966 / 966 | 93% | 5.69 | 490 / 527 |
| ovary | 95% | 1397.31 | 171 / 180 | 97% | 9.11 | 418 / 430 |
| adrenal gland | 99% | 1959.81 | 256 / 258 | 92% | 6.40 | 212 / 230 |
| bladder | 100% | 2405.90 | 21 / 21 | 91% | 5.95 | 458 / 504 |
| breast | 92% | 1376.89 | 421 / 459 | 97% | 9.61 | 1081 / 1118 |
| stomach | 98% | 1542.00 | 351 / 359 | 90% | 5.48 | 258 / 286 |
| kidney | 97% | 1260.20 | 86 / 89 | 88% | 6.78 | 793 / 901 |
| skin | 89% | 1002.44 | 1610 / 1809 | 88% | 8.06 | 414 / 472 |
| liver | 87% | 988.39 | 196 / 226 | 79% | 4.43 | 320 / 406 |
| pancreas | 63% | 503.16 | 205 / 328 | 96% | 7.40 | 170 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 25.36 | 29 / 29 |
| spleen | 100% | 4945.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.29 | 1 / 1 |
| blood vessel | 99% | 2589.50 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 2748.24 | 892 / 929 | 0% | 0 | 0 / 0 |
| adipose | 90% | 1153.29 | 1081 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 7.57 | 40 / 45 |
| heart | 75% | 713.66 | 642 / 861 | 0% | 0 | 0 / 0 |
| muscle | 56% | 493.05 | 446 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 45% | 2.42 | 36 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006906 | Biological process | vesicle fusion |
| GO_0035493 | Biological process | SNARE complex assembly |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0030672 | Cellular component | synaptic vesicle membrane |
| GO_0035577 | Cellular component | azurophil granule membrane |
| GO_0005829 | Cellular component | cytosol |
| GO_0070821 | Cellular component | tertiary granule membrane |
| GO_0035579 | Cellular component | specific granule membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031201 | Cellular component | SNARE complex |
| GO_0043005 | Cellular component | neuron projection |
| GO_0019905 | Molecular function | syntaxin binding |
| GO_0005484 | Molecular function | SNAP receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | VAMP1 |
| Protein name | Vesicle associated membrane protein 1 Vesicle-associated membrane protein 1 (VAMP-1) (Synaptobrevin-1) |
| Synonyms | SYB1 |
| Description | FUNCTION: Involved in the targeting and/or fusion of transport vesicles to their target membrane. |
| Accessions | P23763 F5GZV7 ENST00000396308.4 [P23763-1] ENST00000400911.7 [P23763-2] ENST00000361716.8 [P23763-3] ENST00000535180.5 |
